At PCCA, we’re proud of what we do – helping pharmacists and prescribers create personalized medicine that makes a difference in patients’ lives.
The primary aim of the Trust is to Initiate Clinical Trials of Low Dose Naltrexone for Autoimmune Diseases and Cancers.
We are the voice for pharmacy compounding, advocating for thousands of pharmacists, technicians, students, researchers and suppliers.